• Emerging Technology Insider

TechTalks Video: Richard Schumacher of Pressure BioSciences discusses its UST Early Access Program

The video provides Mr. Schumacher’s insight into Pressure BioSciences recent press release “Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing”


In the TechTalks Video, Mr. Schumacher discusses the strong market demand which led to the company’s decision to access early revenue generating opportunities utilizing the Company’s UltraShear Technology. In the TechTalks Video, he also discusses the processing of high quality nanoemulsions of oil-based ingredients in advance of the company’s planned commercialization during the fourth quarter of this year. Mr. Schumacher also discusses the several contracts that Pressure BioSciences anticipates receiving in the coming months.


The TechTalks video is viewable at https://www.emergingtechnologyinsider.com/techtalks-videos


In the TechTalks video, Mr. Schumacher provides Mr. Schumacher’s insight into Pressure BioSciences recent press release “Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing”


The press release is viewable at https://ir.pressurebiosciences.com/press-releases/detail/394/pressure-biosciences-announces-early-access-program-for-ust


About Pressure BioSciences

Pressure BioSciences, Inc. is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries.

Pressure BioSciences products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction).


Pressure BioSciences’ primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications.


Major new market opportunities have emerged in the use of the Company’s pressure-based technologies in the following areas:


(1) the use of patented BaroFold technology to allow entry into the bio-pharma contract services sector, and

(2) the use of the Company’s recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

For more information please visit www.pressurebiosciences.com.


About TechTalks Videos at Emerging Technology Insider

Emerging Technology Insider, and its TechTalks VIdeos are focused on business and financial opportunities of technology companies globally.


The Emerging Technology Insider website also features news on transactions, financings, strategic relationships, products, services and technology.


For more information please visit https://.EmergingTechnologyInsider.com/lp.


Pressure BioSciences Inc. – Investor Contact

Gary Zwetchkenbaum

Tel. 526 455 7662

Email Gzplumtree@gmail.com